Geron Corporation (NASDAQ:GERN) on Mar. 20 said the U.S. Food and Drug Administration ordered a halt to new patient enrolments in an early-stage trial of its blood cancer drug, imetelstat, over concerns about liver damage. Geron Corporation (NASDAQ:GERN) shares after opening at $2.23 moved to $2.29 on last trade day and at the end of the day closed at $2.21. Company price to sales ratio in past twelve months was calculated as 166.78 and price to cash ratio as 4.28. Geron Corporation (NASDAQ:GERN) showed a positive weekly performance of 20.77%.
Equities research analysts at Raymond James lowered their price target on shares of North American Palladium (NYSEMKT:PAL) from C$0.50 to C$0.30 in a research note issued to investors on Wednesday, Analyst RN reports. Raymond James’ price objective suggests a potential downside of 25.93% from the company’s current price. North American Palladium Ltd (USA) (NYSEMKT:PAL) shares advanced 6.29% in last trading session and ended the day on $0.490. PAL return on equity ratio is recorded as -19.80% and its return on assets is -9.10%. North American Palladium Ltd (USA) (NYSEMKT:PAL) yearly performance is -65.73%.
Forest Oil (NYSE:FST) was downgraded by Simmons to an “underweight” rating in a research note issued on Wednesday, ARN reports. Forest Oil Corporation (NYSE:FST) shares moved up 2.19% in last trading session and was closed at $1.87, while trading in range of $1.78 – $1.88. Forest Oil Corporation (NYSE:FST) year to date (YTD) performance is -48.20%.
Barrington Research cut shares of Golden Star Resources (NYSE:GSS) to a market perform rating in a research report sent to investors on Wednesday morning, Analyst RN reports. Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) weekly performance is -23.38%. On last trading day company shares ended up $0.598. Golden Star Resources Ltd. (USA) (NYSEMKT:GSS) distance from 50-day simple moving average (SMA50) is -12.98%. Analysts mean target price for the company is $0.48.
Leave a Reply